Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Imatinib BNM Imatinib mesilate 119.5mg equivalent to imatinib 100mg Film coated tablet Boucher & Muir (New Zealand) Limited t/a BNM Group Sun Pharmaceutical Industries Limited, Paonta Sahib, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Imatinib BNM Imatinib mesilate 478mg equivalent to imatinib 400mg Film coated tablet Boucher & Muir (New Zealand) Limited t/a BNM Group Sun Pharmaceutical Industries Limited, Paonta Sahib, India
|
Dated this 9th day of November 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).